Abstract

Epithelial cells from the human benign prostate express melatonin receptors which effect transient suppression of DNA synthesis and sustained attenuation of growth. The role of transforming growth factor-beta1 (TGFbeta1), which is produced in prostate epithelial cells and inhibits their growth, was examined in the action of melatonin. The effects of melatonin and TGFbeta1 and their combination on (3)H-thymidine incorporation were assessed. The possibility that melatonin effected TGFbeta1 release from cells was studied. Incubation of the cells with TGFbeta1 resulted in a time- and dose-dependent inhibition of (3)H-thymidine incorporation into cells. Melatonin (10-500 pM) inhibited (3)H-thymidine incorporation, and its effects were attenuated at higher (1-10 nM) concentrations. In the presence of submaximal doses of TGFbeta1, the inhibitory effect of melatonin was maintained over the entire concentration range tested (10 pM-10 nM). The inhibition of (3)H-thymidine incorporation by TGFbeta1 was more pronounced in the absence of dihydrotestosterone (DHT) than in its presence, and melatonin had no further effect. Melatonin enhanced the release of proteins from cells, among them proteins recognized by specific TGFbeta1 antisera. The TGFbeta1-neutralizing antisera prevented the inhibitory action of melatonin on (3)H-thymidine incorporation into cells. These data indicate a role for TGFbeta1 in the melatonin-mediated attenuation of benign prostate epithelial cell growth.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.